Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication
暂无分享,去创建一个
J Ratajczak | M. Ratajczak | M Z Ratajczak | J. Ratajczak | A. Janowska-Wieczorek | M. Wysoczynski | M Wysoczynski | F Hayek | A Janowska-Wieczorek | F. Hayek
[1] B. Østerud. The role of platelets in decrypting monocyte tissue factor. , 2001, Disease-a-month : DM.
[2] G. Grondin,et al. Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena. , 1991, Biochimica et biophysica acta.
[3] J. Schifferli,et al. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. , 2004, Blood.
[4] H. Hoogsteden,et al. Proteomic analysis of exosomes secreted by human mesothelioma cells. , 2004, The American journal of pathology.
[5] Anna Janowska-Wieczorek,et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer , 2005, International journal of cancer.
[6] Michael Gnant,et al. Impact of pretreatment thrombocytosis on survival in primary breast cancer , 2003, Thrombosis and Haemostasis.
[7] C. Prowse,et al. The release of prion protein from platelets during storage of apheresis platelets , 2001, Transfusion.
[8] M. Ratajczak,et al. Biological Significance of the Different Erythropoietic Factors Secreted by Normal Human Early Erythroid Cells , 2003, Leukemia & lymphoma.
[10] J. Sixma,et al. Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules , 1999 .
[11] M. Mesri,et al. Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway* , 1999, The Journal of Biological Chemistry.
[12] V. Dolo,et al. Membrane vesicles in ovarian cancer fluids: a new potential marker. , 1999, Anticancer research.
[13] T. Whiteside. Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system? , 2005, British Journal of Cancer.
[14] C. Prowse,et al. The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components , 2006, Transfusion.
[15] A. Fonteh,et al. Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells. , 1997, Carcinogenesis.
[16] A. Gregor,et al. Apoptosis in human primary brain tumours: actions of arachidonic acid. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.
[17] P. Wolf. The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.
[18] M. Ratajczak,et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. , 2001, Blood.
[19] J. Schifferli,et al. Microparticles released by human neutrophils adhere to erythrocytes in the presence of complement. , 2005, Experimental cell research.
[20] I. Shiojima,et al. Sphingosine 1-Phosphate Activates Akt, Nitric Oxide Production, and Chemotaxis through a GiProtein/Phosphoinositide 3-Kinase Pathway in Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[21] K. Honn,et al. Platelets and Cancer Metastasis: More Than an Epiphenomenon , 1992, Seminars in thrombosis and hemostasis.
[22] L. McManus,et al. Isolation of human platelet membrane microparticles from plasma and serum , 1982 .
[23] M. Ratajczak,et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes , 2006, Cancer Immunology, Immunotherapy.
[24] J. Freyssinet,et al. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors , 2004, Current opinion in hematology.
[25] P. Musiani,et al. Polymorphonuclear Leukocyte Apoptosis Is Inhibited by Platelet-released Mediators, Role of TGFβ-1 , 2000, Thrombosis and Haemostasis.
[26] D. Hoon,et al. Circulating Nucleic Acids and Proteomics of Plasma/Serum: Clinical Utility , 2004, Annals of the New York Academy of Sciences.
[27] C. Huang,et al. Roles of phospholipid signaling in chemoattractant-induced responses. , 2000, Journal of cell science.
[28] P. Comfurius,et al. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. , 2004, Biochimica et biophysica acta.
[29] P. Collas,et al. Reprogrammed gene expression in a somatic cell‐free extract , 2002, EMBO reports.
[30] M. Ratajczak,et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. , 2001, Blood.
[31] A. Schroit,et al. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. , 1997, Blood.
[32] L. Horstman,et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. , 1993, Thrombosis research.
[33] C. Hess,et al. Ectosomes released by human neutrophils are specialized functional units. , 1998, Journal of immunology.
[34] A. Levine,et al. The regulation of exosome secretion: a novel function of the p53 protein. , 2006, Cancer research.
[35] L. Horstman,et al. New horizons in the analysis of circulating cell-derived microparticles. , 2004, The Keio journal of medicine.
[36] H. K. Kim,et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. , 2003, European journal of cancer.
[37] F. Saladino,et al. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. , 1998, Anticancer research.
[38] José A López,et al. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. , 2005, Blood.
[39] A. Zeiher,et al. Vitamin C Inhibits Endothelial Cell Apoptosis in Congestive Heart Failure , 2001, Circulation.
[40] B. Osterud. The role of platelets in decrypting monocyte tissue factor. , 2001, Seminars in hematology.
[41] S. Levine,et al. Mechanisms of Soluble Cytokine Receptor Generation , 2004, The Journal of Immunology.
[42] M. Ratajczak,et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV , 2003, AIDS.
[43] H. Brühl,et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.
[44] G. Parrinello,et al. Evaluation of Soluble Fas Ligand as a Serological Marker for Melanoma , 2002, Dermatology.
[45] D. Pisetsky,et al. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. , 2005, Arthritis and rheumatism.
[46] G. Raposo,et al. Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.
[47] A. Kakkar,et al. Platelets and cancer. , 2002, The Lancet. Oncology.
[48] M. Herlyn,et al. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. , 2005, The journal of investigative dermatology. Symposium proceedings.
[49] Y. Lévy,et al. Muscle involvement in human immunodeficiency virus‐infected patients is associated with marked selenium deficiency , 1997, Muscle & nerve.
[50] G. Raposo,et al. Exosomes: A Bubble Ride for Prions? , 2005, Traffic.
[51] C. Hess,et al. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. , 2003, Experimental cell research.
[52] Hans-Hermann Gerdes,et al. Nanotubular Highways for Intercellular Organelle Transport , 2004, Science.
[53] S. Baylin,et al. Hematopoietic stem cells convert into liver cells within days without fusion , 2004, Nature Cell Biology.
[54] B. Pace,et al. Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation. , 2001, Blood.
[55] H. Hemker,et al. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis". , 1996, The Journal of clinical investigation.
[56] Y. Okada,et al. Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasis , 1995, International journal of cancer.
[57] L. Edmunds,et al. Interaction of leukocytes with platelet microparticles derived from outdated platelet concentrates. , 1998, Thrombosis and haemostasis.
[58] G. FitzGerald,et al. Arachidonic Acid in Platelet Microparticles Up-regulates Cyclooxygenase-2-dependent Prostaglandin Formation via a Protein Kinase C/Mitogen-activated Protein Kinase-dependent Pathway* , 1999, The Journal of Biological Chemistry.
[59] L. Edmunds,et al. Measurement of Platelet Microparticles during Cardiopulmonary Bypass by Means of Captured ELISA for GPIIb/IIIa , 1998, Thrombosis and Haemostasis.
[60] J. Rak,et al. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. , 2006, Seminars in thrombosis and hemostasis.
[61] T. Greenwalt,et al. The how and why of exocytic vesicles , 2006, Transfusion.
[62] Darwin J. Prockop,et al. Mitochondrial transfer between cells can rescue aerobic respiration , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[63] S. Eaton,et al. Argosomes A Potential Vehicle for the Spread of Morphogens through Epithelia , 2001, Cell.
[64] K. O'Connor,et al. Vesicle traffic through intercellular bridges in DU 145 human prostate cancer cells , 2004, Journal of cellular and molecular medicine.
[65] Jichun Chen,et al. Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after erythrocyte transfusion in paroxysmal nocturnal hemoglobinuria. , 2004, Blood.
[66] S. Booth,et al. Cellular prion protein is released on exosomes from activated platelets. , 2006, Blood.
[67] G. FitzGerald,et al. Mechanisms of Cellular Activation by Platelet Microparticles , 1999, Thrombosis and Haemostasis.
[68] B. Fadeel. Plasma membrane alterations during apoptosis: role in corpse clearance. , 2004, Antioxidants & redox signaling.
[69] H. Kleinman,et al. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. , 2002, Cancer research.
[70] Graça Raposo,et al. Exosomal-like vesicles are present in human blood plasma. , 2005, International immunology.
[71] P. Ponsaerts,et al. Modulation of cellular behavior by exogenous messenger RNA , 2006, Leukemia.
[72] D. Brindley,et al. Platelet-released phospholipids link haemostasis and angiogenesis. , 2001, Cardiovascular research.
[73] A. Booth,et al. The Trojan exosome hypothesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[74] R. Nieuwland,et al. Microparticles in cardiovascular diseases. , 2003, Cardiovascular research.
[75] G. Barbarini,et al. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. , 1998, The New England journal of medicine.
[76] G. FitzGerald,et al. Modulation of monocyte-endothelial cell interactions by platelet microparticles. , 1998, The Journal of clinical investigation.
[77] G. Mack. Trial set to test how stem cells heal a broken heart , 2006, Nature Medicine.
[78] P. Sims,et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.
[79] D. Praticò,et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. , 2002, Experimental hematology.
[80] Z. Darżynkiewicz,et al. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. , 2000, Experimental cell research.
[81] Jayoung Kim,et al. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. , 2005, The Journal of clinical investigation.
[82] J. Freyssinet,et al. Membrane microparticles: two sides of the coin. , 2005, Physiology.
[83] J Ratajczak,et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery , 2006, Leukemia.
[84] H. Schöler,et al. Nuclei of Embryonic Stem Cells Reprogram Somatic Cells , 2004, Stem cells.
[85] G. FitzGerald,et al. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. , 1997, The Journal of clinical investigation.
[86] Anthony S. Fauci,et al. Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.
[87] D. Taub,et al. Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice. , 1997, The Journal of clinical investigation.
[88] G. Raposo,et al. Endosomes, exosomes and Trojan viruses. , 2004, Trends in microbiology.
[89] M. Ratajczak,et al. Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants , 2002, Leukemia.
[90] K. Shedden,et al. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. , 2003, Cancer research.